I think that Kakala is essentially right in seeing MSB as a $6 stock for the time being. I think the market has determined that nothing short of full FDA approval of CHF will shift the sp and that is going to be 2 or 3 years off and may never happen (even the positive analysts at Bell Potter estimate there's a 40% chance it will fail). Having said that, if it succeeds (60% chance) that's got to see a trippling of the sp. I don't think the upcoming Diabetes trial results will make any difference to the sp either.
I spent this week looking at what other stem cell companies are doing and a lot of them are reporting successes in the same indications at phase 1/2 level and their market capitalisation are a fraction of MSB so we can't expect positive Phase 2 announcements to shift the sp.
- Forums
- ASX - By Stock
- MSB
- analysts
analysts, page-22
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.8¢ |
Change
0.003(0.27%) |
Mkt cap ! $1.059B |
Open | High | Low | Value | Volume |
94.0¢ | 94.0¢ | 92.5¢ | $774.9K | 831.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 243388 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 34886 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 243388 | 0.925 |
28 | 315504 | 0.920 |
18 | 202231 | 0.915 |
10 | 226049 | 0.910 |
5 | 33181 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 34103 | 22 |
0.935 | 83262 | 16 |
0.940 | 82618 | 12 |
0.945 | 189822 | 10 |
0.950 | 15535 | 4 |
Last trade - 14.21pm 10/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |